hiv” by Trending Topics 2019 licensed under CC BY 2.0

 

Source: CNBC

The American biotech company, Gilead Sciences, came to an agreement with the administration to donate an HIV transmission prevention drug, Truvada, for 200,000 Americans every year.

The agreement is expected to last through 2025, providing thousands of individuals with the drug, which usually costs upwards of $1,600 a month. The administration apparently agreed to cover the costs for getting those medications to people in need.

The donation, Trump tweeted, “Will help us achieve our goal of ending the HIV epidemic in America!”

Across the globe there are more than 36 million people living with HIV, and approximately 21 million of those individuals are using drug treatments to help suppress the infection, according to CNBC.

Read Full Story: CNBC

Contact mOppenheimTV

video-banner-fpo
Thank you for your interest in mOppenheimTV. Do you have a question or comment about our programs or services? Please get in touch with us! We welcome any feedback you may have.

Your Name (required)

Your Organization (required)

Your Email (required)

Your Phone (required)

Subject (required) - check any that apply
INSIGHTNonprofit SpotlightPBS CollaborationExecutive SearchOther

Your Message

To submit, please enter the characters below into the bottom field:
[recaptcha class:mtv-recaptcha]

Biotech Company Agreement with Administration Will Provide 200,000 People in the U.S. with Treatment for HIV

Health, News |